N/A
Completed N=5
Health Through Activity: A Pilot Study of a Rehabilitation Intervention for People Living With Multiple Myeloma
Source: ClinicalTrials.gov NCT05700747 ↗Enrolled (actual)
5
Serious AEs
0.0%
Results posted
Dec 2025
Primary outcomePrimary: Rate of Participant Enrollment — 5 Participants
Summary
The purpose of this study is to explore whether a structured program can help reduce the challenges of decreased physical functioning and quality of life for participants with multiple myeloma by providing a customized exercise program and fostering engagement in meaningful activities.
The name of the study intervention involved in this study is:
Health Through Activity (HTA) (six-session, rehabilitation exercise regimen)
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Rate of Participant Enrollment |
5 | — |
| PRIMARY Assessment Completion Rate |
5 | — |
| PRIMARY Screening Rate |
11 | — |
| PRIMARY Eligibility Rate |
5 | — |
| SECONDARY Intervention Completion Rate |
5 | — |
| SECONDARY Participant Satisfaction |
5; 3; 3; 5; 5; 5 | — |
Eligibility Criteria
Inclusion Criteria
-≥18 years of age
- Diagnosed with multiple myeloma currently receiving maintenance therapy,
- Experiencing disability as indicated by an answer of "yes" to the question "Do health problems interfere with your ability to carry out your social or day to day activities?"
Exclusion Criteria
- Bone pain that is either a) new onset or increased in the past month or b) uncontrolled i.e., in the patient's estimation the bone pain "greatly interferes with daily activities"
- History of fracture in the past 12 months without fixation, or
- Any injury or medical condition that would prohibit being able to safely perform exercise as indicated by the Physical Activity Readiness Questionnaire[29] (i.e., atrial fibrillation, chest pain or angina, uncontrolled high blood pressure or hypertension, loss of balance due to dizziness in the past 12 months, or loss of consciousness in the past 12 months).
- We will also exclude individuals with moderate or worse cognitive impairment as indicated by a score of 3 or less on the Callahan six item cognitive screening tool.
Data sourced from ClinicalTrials.gov (NCT05700747). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.